Fig. 2From: Complete response to neoadjuvant chemoradiotherapy in rectal cancer is associated with RAS/AKT mutations and high tumour mutational burdenDifferences in genomic characteristics between responders and non-responders. A Tumour mutational burden in mutations/megabase; B Structural variants per sample; C Numbers of neoantigens per sample; D Change in Tumour mutational burden in paired samples pre and post response; E MATH score per sampleBack to article page